|
1
|
De Greef D, Barton EM, Sandberg EN, Croley
CR, Pumarol J, Wong TL, Das N and Bishayee A: Anticancer potential
of garlic and its bioactive constituents: A systematic and
comprehensive review. Semin Cancer Biol. 73:219–264.
2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Ryu K, Ide N, Matsuura H and Itakura Y: N
alpha-(1-deoxy-D-fructos-1-yl)-L-arginine, an antioxidant compound
identified in aged garlic extract. J Nutr. 131:972S–976S.
2001.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Matsutomo T: Potential benefits of garlic
and other dietary supplements for the management of hypertension.
Exp Ther Med. 19:1479–1484. 2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Ohtani M and Nishimura T: The preventive
and therapeutic application of garlic and other plant ingredients
in the treatment of periodontal diseases. Exp Ther Med.
19:1507–1510. 2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Tanaka S, Haruma K, Yoshihara M, Kajiyama
G, Kira K, Amagase H and Chayama K: Aged garlic extract has
potential suppressive effect on colorectal adenomas in humans. J
Nutr. 136 (Suppl 3):821S–826S. 2006.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Jikihara H, Qi G, Nozoe K, Hirokawa M,
Sato H, Sugihara Y and Shimamoto F: Aged garlic extract inhibits
1,2-dimethylhydrazine-induced colon tumor development by
suppressing cell proliferation. Oncol Rep. 33:1131–1140.
2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Ohkubo S, Dalla Via L, Grancara S,
Kanamori Y, García-Argáez AN, Canettieri G, Arcari P, Toninello A
and Agostinelli E: The antioxidant, aged garlic extract, exerts
cytotoxic effects on wild-type and multidrug-resistant human cancer
cells by altering mitochondrial permeability. Int J Oncol.
53:1257–1268. 2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Ishikawa H, Saeki T, Otani T, Suzuki T,
Shimozuma K, Nishino H, Fukuda S and Morimoto K: Aged garlic
extract prevents a decline of NK cell number and activity in
patients with advanced cancer. J Nutr. 136 (Suppl 3):816S–820S.
2006.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Li WQ, Zhang JY, Ma JL, Li ZX, Zhang L,
Zhang Y, Guo Y, Zhou T, Li JY, Shen L, et al: Effects of
Helicobacter pylori treatment and vitamin and garlic
supplementation on gastric cancer incidence and mortality:
Follow-up of a randomized intervention trial. BMJ.
366(l5016)2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Rawla P, Sunkara T and Gaduputi V:
Epidemiology of pancreatic cancer: Global trends, etiology and risk
factors. World J Oncol. 10:10–27. 2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Michaud DS: Role of bacterial infections
in pancreatic cancer. Carcinogenesis. 34:2193–2197. 2013.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Thomas RM and Jobin C: Microbiota in
pancreatic health and disease: The next frontier in microbiome
research. Nat Rev Gastroenterol Hepatol. 17:53–64. 2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Abe S, Masuda A, Matsumoto T, Inoue J,
Toyama H, Sakai A, Kobayashi T, Tanaka T, Tsujimae M, Yamakawa K,
et al: Impact of intratumoral microbiome on tumor immunity and
prognosis in human pancreatic ductal adenocarcinoma. J
Gastroenterol. 59:250–262. 2024.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Tan Q, Ma X, Yang B, Liu Y, Xie Y, Wang X,
Yuan W and Ma J: Periodontitis pathogen Porphyromonas
gingivalis promotes pancreatic tumorigenesis via neutrophil
elastase from tumor-associated neutrophils. Gut Microbes.
14(2073785)2022.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Saba E, Farhat M, Daoud A, Khashan A,
Forkush E, Menahem NH, Makkawi H, Pandi P, Angabo S, Kawasaki H, et
al: Oral bacteria accelerate pancreatic cancer development in mice.
Gut. 73:770–786. 2024.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Udayasuryan B, Ahmad RN, Nguyen TTD, Umaña
A, Roberts LDM, Sobol P, Jones SD, Munson JM, Slade DJ and
Verbridge SS: Fusobacterium nucleatum induces proliferation
and migration in pancreatic cancer cells through host autocrine and
paracrine signaling. Sci Signal. 15(eabn4948)2022.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Hayashi M, Ikenaga N, Nakata K, Luo H,
Zhong PS, Date S, Oyama K, Higashijima N, Kubo A, Iwamoto C, et al:
Intratumor Fusobacterium nucleatum promotes the progression
of pancreatic cancer via the CXCL1-CXCR2 axis. Cancer Sci.
114:3666–3678. 2023.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Zini A, Mann J, Mazor S and Vered Y:
Beneficial effect of aged garlic extract on periodontitis: A
randomized controlled double-blind clinical study. J Clin Biochem
Nutr. 67:297–301. 2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Chan JM, Wang F and Holly EA: Vegetable
and fruit intake and pancreatic cancer in a population-based
case-control study in the San Francisco bay area. Cancer Epidemiol
Biomarkers Prev. 14:2093–2097. 2005.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Abe K, Hori Y and Myoda T: Volatile
compounds of fresh and processed garlic. Exp Ther Med.
19:1585–1593. 2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Trio PZ, You S, He X, He J, Sakao K and
Hou DX: Chemopreventive functions and molecular mechanisms of
garlic organosulfur compounds. Food Funct. 5:833–844.
2014.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Singh P, Patel M, Bhowmik D, Kumari N,
Prajapati SK and Gupta R: Identification of common biomarkers
affecting patient survival in cancers. World Acad Sci J.
6(53)2024.
|
|
23
|
Lu L, Gao Z, Song J, Jin L and Liang Z:
The potential of diallyl trisulfide for cancer prevention and
treatment, with mechanism insights. Front Cell Dev Biol.
12(1450836)2024.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Sarhadi VK and Armengol G: Molecular
biomarkers in cancer. Biomolecules. 12(1021)2022.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Sugiura R, Satoh R and Takasaki T: ERK: A
double-edged sword in cancer. ERK-dependent apoptosis as a
potential therapeutic strategy for cancer. Cells.
10(2509)2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Lan XY, Sun HY, Liu JJ, Lin Y, Zhu ZY, Han
X, Sun X, Li XR, Zhang HC and Tang ZY: Effects of garlic oil on
pancreatic cancer cells. Asian Pac J Cancer Prev. 14:5905–5910.
2013.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Chhabria SV, Akbarsha MA, Li AP, Kharkar
PS and Desai KB: In situ allicin generation using targeted
alliinase delivery for inhibition of MIA PaCa-2 cells via
epigenetic changes, oxidative stress and cyclin-dependent kinase
inhibitor (CDKI) expression. Apoptosis. 20:1388–1409.
2015.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Wang CJ, Wang C, Han J, Wang YK, Tang L,
Shen DW, Zhao Y, Xu RH and Zhang H: Effect of combined treatment
with recombinant interleukin-2 and allicin on pancreatic cancer.
Mol Biol Rep. 40:6579–6585. 2013.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Saini V, Manral A, Arora R, Meena P,
Gusain S, Saluja D and Tiwari M: Novel synthetic analogs of diallyl
disulfide triggers cell cycle arrest and apoptosis via ROS
generation in MIA PaCa-2 cells. Pharmacol Rep. 69:813–821.
2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Ma HB, Huang S, Yin XR, Zhang Y and Di ZL:
Apoptotic pathway induced by diallyl trisulfide in pancreatic
cancer cells. World J Gastroenterol. 20:193–203. 2014.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Lee HJ, Jeong JH and Ryu JH:
Anti-pancreatic cancer activity of Z-ajoene from garlic: An
inhibitor of the Hedgehog/Gli/FoxM1 axis. J Funct Foods.
56:102–109. 2019.
|
|
32
|
Wang W, Cheng J and Zhu Y: The JNK
signaling pathway is a novel molecular target for
S-propargyl-L-cysteine, a naturally-occurring garlic derivatives:
Link to its anticancer activity in pancreatic cancer in vitro and
in vivo. Curr Cancer Drug Targets. 15:613–623. 2015.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Murtaugh LC and Keefe MD: Regeneration and
repair of the exocrine pancreas. Annu Rev Physiol. 77:229–249.
2015.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Sidhapuriwala JN, Hegde A, Ang AD, Zhu YZ
and Bhatia M: Effects of S-propargyl-cysteine (SPRC) in
caerulein-induced acute pancreatitis in mice. PLoS One.
7(e32574)2012.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Mathan Kumar M and Tamizhselvi R:
Protective effect of diallyl disulfide against cerulein-induced
acute pancreatitis and associated lung injury in mice. Int
Immunopharmacol. 80(106136)2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Marimuthu MK, Moorthy A and Ramasamy T:
Diallyl disulfide attenuates STAT3 and NF-κB pathway through PPAR-γ
activation in cerulein-induced acute pancreatitis and associated
lung injury in mice. Inflammation. 45:45–58. 2022.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Orján EM, Kormányos ES, Fűr GM, Dombi A,
Bálint ER, Balla Z, Balog BA, Dágó A, Totonji A, Bátai ZI, et al:
The anti-inflammatory effect of dimethyl trisulfide in experimental
acute pancreatitis. Sci Rep. 13(16813)2023.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Lunova M, Zizer E, Kucukoglu O, Schwarz C,
Dillmann WH, Wagner M and Strnad P: Hsp72 overexpression
accelerates the recovery from caerulein-induced pancreatitis. PLoS
One. 7(e39972)2012.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Hamada S, Masamune A and Shimosegawa T:
Novel therapeutic strategies targeting tumor-stromal interactions
in pancreatic cancer. Front Physiol. 4(331)2013.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Saiki Y, Hirota S and Horii A: Attempts to
remodel the pathways of gemcitabine metabolism: Recent approaches
to overcoming tumours with acquired chemoresistance. Cancer drug
Resist. 3:819–831. 2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Patel M, Singh P, Gandupalli L and Gupta
R: Identification and evaluation of survival-associated common
chemoresistant genes in cancer. Biomed Biotechnol Res J. 8:320–327.
2024.
|
|
42
|
Ozalp Unal D and Sel T: Investigation of
antiproliferative effects of combinations of white and black garlic
extracts with 5-fluorouracil (5-FU) on caco-2 colorectal
adenocarcinoma cells. Mol Nutr Food Res.
68(e2300820)2024.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Perez-Ortiz JM, Galan-Moya EM, de la
Cruz-Morcillo MA, Rodriguez JF, Gracia I, Garcia MT and
Redondo-Calvo FJ: Cost effective use of a thiosulfinate-enriched
Allium sativum extract in combination with chemotherapy in
colon cancer. Int J Mol Sci. 21(2766)2020.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Horie T, Awazu S, Itakura Y and Fuwa T:
Alleviation by garlic of antitumor drug-induced damage to the
intestine. J Nutr. 131 (3s):1071S–1074S. 2001.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Petrovic V, Nepal A, Olaisen C, Bachke S,
Hira J, Søgaard CK, Røst LM, Misund K, Andreassen T, Melø TM, et
al: Anti-cancer potential of homemade fresh garlic extract is
related to increased endoplasmic reticulum stress. Nutrients.
10(450)2018.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Zou X, Liang J, Sun J, Hu X, Lei L, Wu D
and Liu L: Allicin sensitizes hepatocellular cancer cells to
anti-tumor activity of 5-fluorouracil through ROS-mediated
mitochondrial pathway. J Pharmacol Sci. 131:233–240.
2016.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Khakbaz P, Panahizadeh R, Vatankhah MA and
Najafzadeh N: Allicin reduces 5-fluorouracil-resistance in gastric
cancer cells through modulating MDR1, DKK1, and WNT5A expression.
Drug Res (Stuttg). 71:448–454. 2021.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Țigu AB, Toma VA, Moț AC, Jurj A, Moldovan
CS, Fischer-Fodor E, Berindan-Neagoe I and Pârvu M: The synergistic
antitumor effect of 5-fluorouracil combined with allicin against
lung and colorectal carcinoma cells. Molecules.
25(1947)2020.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Gao X, Xu C, Santhanam RK, Zhang Y and
Zhao Q: Allicin: A natural weapon against Taxol resistance in
non-small cell lung cancer through cathepsin B inhibition and
lysosomal-autophagy disruption. Food Front. 1–14. 2024.
|
|
50
|
Su J, Xia H, He H, Tang H, Zhou J, Xun Y,
Liu F, Su B and Su Q: Diallyl disulfide antagonizes DJ-1 mediated
proliferation, epithelial-mesenchymal transition, and
chemoresistance in gastric cancer cells. Environ Toxicol.
39:4105–4119. 2024.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Malla R, Marni R, Chakraborty A and Kamal
MA: Diallyl disulfide and diallyl trisulfide in garlic as novel
therapeutic agents to overcome drug resistance in breast cancer. J
Pharm Anal. 12:221–231. 2022.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Hassan HT: Ajoene (natural garlic
compound): A new anti-leukaemia agent for AML therapy. Leuk Res.
28:667–671. 2004.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Raisuddin S, Ahmad S, Fatima M and Dabeer
S: Toxicity of anticancer drugs and its prevention with special
reference to role of garlic constituents. Ann Phytomed. 7:13–26.
2018.
|
|
54
|
Zhang QY, Wang FX, Jia KK and Kong LD:
Natural product interventions for chemotherapy and
radiotherapy-induced side effects. Front Pharmacol.
9(1253)2018.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Geller LT, Barzily-Rokni M, Danino T,
Jonas OH, Shental N, Nejman D, Gavert N, Zwang Y, Cooper ZA, Shee
K, et al: Potential role of intratumor bacteria in mediating tumor
resistance to the chemotherapeutic drug gemcitabine. Science.
357:1156–1160. 2017.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Riquelme E, Zhang Y, Zhang L, Montiel M,
Zoltan M, Dong W, Quesada P, Sahin I, Chandra V, San Lucas A, et
al: Tumor microbiome diversity and composition influence pancreatic
cancer outcomes. Cell. 178:795–806.e12. 2019.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Del Castillo E, Meier R, Chung M, Koestler
DC, Chen T, Paster BJ, Charpentier KP, Kelsey KT, Izard J and
Michaud DS: The microbiomes of pancreatic and duodenum tissue
overlap and are highly subject specific but differ between
pancreatic cancer and noncancer subjects. Cancer Epidemiol
Biomarkers Prev. 28:370–383. 2019.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Nagata N, Nishijima S, Kojima Y, Hisada Y,
Imbe K, Miyoshi-Akiyama T, Suda W, Kimura M, Aoki R, Sekine K, et
al: Metagenomic identification of microbial signatures predicting
pancreatic cancer from a multinational study. Gastroenterology.
163:222–238. 2022.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Pushalkar S, Hundeyin M, Daley D,
Zambirinis CP, Kurz E, Mishra A, Mohan N, Aykut B, Usyk M, Torres
LE, et al: The pancreatic cancer microbiome promotes oncogenesis by
induction of innate and adaptive immune suppression. Cancer Discov.
8:403–416. 2018.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Maisonneuve P, Amar S and Lowenfels AB:
Periodontal disease, edentulism, and pancreatic cancer: A
meta-analysis. Ann Oncol. 28:985–995. 2017.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Kawasaki H and Amano H: Anti-inflammatory
role of microRNA-429 in human gingival epithelial cells-inhibition
of IL-8 production through direct binding to IKKβ mRNA. Mol Med
Rep. 24(581)2021.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Michaud DS, Izard J, Wilhelm-Benartzi CS,
You DH, Grote VA, Tjønneland A, Dahm CC, Overvad K, Jenab M,
Fedirko V, et al: Plasma antibodies to oral bacteria and risk of
pancreatic cancer in a large European prospective cohort study.
Gut. 62:1764–1770. 2013.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Fan X, Alekseyenko AV, Wu J, Peters BA,
Jacobs EJ, Gapstur SM, Purdue MP, Abnet CC, Stolzenberg-Solomon R,
Miller G, et al: Human oral microbiome and prospective risk for
pancreatic cancer: A population-based nested case-control study.
Gut. 67:120–127. 2018.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Mitsuhashi K, Nosho K, Sukawa Y, Matsunaga
Y, Ito M, Kurihara H, Kanno S, Igarashi H, Naito T, Adachi Y, et
al: Association of Fusobacterium species in pancreatic
cancer tissues with molecular features and prognosis. Oncotarget.
6:7209–7220. 2015.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Gnanasekaran J, Gallimidi AB, Saba E,
Pandi K, Berchoer LE, Hermano E, Angabo S, Makkawi H, Khashan A,
Daoud A, et al: Intracellular Porphyromonas gingivalis
promotes the tumorigenic behavior of pancreatic carcinoma cells.
Cancers (Basel). 12(2331)2020.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Shams-Ghahfarokhi M, Shokoohamiri MR,
Amirrajab N, Moghadasi B, Ghajari A, Zeini F, Sadeghi G and
Razzaghi-Abyaneh M: In vitro antifungal activities of Allium cepa,
Allium sativum and ketoconazole against some pathogenic
yeasts and dermatophytes. Fitoterapia. 77:321–323. 2006.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Nakamoto M, Kunimura K, Suzuki J and
Kodera Y: Antimicrobial properties of hydrophobic compounds in
garlic: Allicin, vinyldithiin, ajoene and diallyl polysulfides. Exp
Ther Med. 19:1550–1553. 2020.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Ohta R, Yamada N, Kaneko H, Ishikawa K,
Fukuda H, Fujino T and Suzuki A: In vitro inhibition of the growth
of Helicobacter pylori by oil-macerated garlic constituents.
Antimicrob Agents Chemother. 43:1811–1812. 1999.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Cellini L, Di Campli E, Masulli M, Di
Bartolomeo S and Allocati N: Inhibition of Helicobacter
pylori by garlic extract (Allium sativum). FEMS Immunol
Med Microbiol. 13:273–277. 1996.PubMed/NCBI View Article : Google Scholar
|
|
70
|
O'Gara EA, Hill DJ and Maslin DJ:
Activities of garlic oil, garlic powder, and their diallyl
constituents against Helicobacter pylori. Appl Environ
Microbiol. 66:2269–2273. 2000.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Iimuro M, Shibata H, Kawamori T, Matsumoto
T, Arakawa T, Sugimura T and Wakabayashi K: Suppressive effects of
garlic extract on Helicobacter pylori-induced gastritis in
Mongolian gerbils. Cancer Lett. 187:61–68. 2002.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Müller A, Eller J, Albrecht F, Prochnow P,
Kuhlmann K, Bandow JE, Slusarenko AJ and Leichert LIO: Allicin
induces thiol stress in bacteria through S-allylmercapto
modification of protein cysteines. J Biol Chem. 291:11477–11490.
2016.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Petropoulos S, Fernandes Â, Barros L,
Ciric A, Sokovic M and Ferreira ICFR: Antimicrobial and antioxidant
properties of various Greek garlic genotypes. Food Chem. 245:7–12.
2018.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Fujisawa H, Watanabe K, Suma K, Origuchi
K, Matsufuji H, Seki T and Ariga T: Antibacterial potential of
garlic-derived allicin and its cancellation by sulfhydryl
compounds. Biosci Biotechnol Biochem. 73:1948–1955. 2009.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Bachrach G, Jamil A, Naor R, Tal G, Ludmer
Z and Steinberg D: Garlic allicin as a potential agent for
controlling oral pathogens. J Med Food. 14:1338–1343.
2011.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Bakri IM and Douglas CWI: Inhibitory
effect of garlic extract on oral bacteria. Arch Oral Biol.
50:645–651. 2005.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Shetty S, Thomas B, Shetty V, Bhandary R
and Shetty R: An in-vitro evaluation of the efficacy of garlic
extract as an antimicrobial agent on periodontal pathogens: A
microbiological study. Ayu. 34:445–451. 2013.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Velliyagounder K, Ganeshnarayan K,
Velusamy SK and Fine DH: In vitro efficacy of diallyl sulfides
against the periodontopathogen Aggregatibacter
actinomycetemcomitans. Antimicrob Agents Chemother.
56:2397–2407. 2012.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Aykut B, Pushalkar S, Chen R, Li Q,
Abengozar R, Kim JI, Shadaloey SA, Wu D, Preiss P, Verma N, et al:
The fungal mycobiome promotes pancreatic oncogenesis via activation
of MBL. Nature. 574264–267. 2019.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Okuno K, Tokunaga M, Von Hoff D, Kinugasa
Y and Goel A: PDAC Biomarker Working Group. Intratumoral
Malassezia globosa levels predict survival and therapeutic
response to adjuvant chemotherapy in patients with pancreatic
ductal adenocarcinoma. Gastroenterology. 165:502–504.e2.
2023.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Narunsky-Haziza L, Sepich-Poore GD,
Livyatan I, Asraf O, Martino C, Nejman D, Gavert N, Stajich JE,
Amit G, González A, et al: Pan-cancer analyses reveal
cancer-type-specific fungal ecologies and bacteriome interactions.
Cell. 185:3789–3806.e17. 2022.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Alam A, Levanduski E, Denz P,
Villavicencio HS, Bhatta M, Alhorebi L, Zhang Y, Gomez EC, Morreale
B, Senchanthisai S, et al: Fungal mycobiome drives IL-33 secretion
and type 2 immunity in pancreatic cancer. Cancer Cell.
40:153–167.e11. 2022.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Brayer KJ, Hanson JA, Cingam S, Martinez
C, Ness SA and Rabinowitz I: The inflammatory response of human
pancreatic cancer samples compared to normal controls. PLoS One.
18(e0284232)2023.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Kunovsky L, Dite P, Jabandziev P, Dolina
J, Vaculova J, Blaho M, Bojkova M, Dvorackova J, Uvirova M, Kala Z
and Trna J: Helicobacter pylori infection and other bacteria
in pancreatic cancer and autoimmune pancreatitis. World J
Gastrointest Oncol. 13:835–844. 2021.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Nilsson HO, Stenram U, Ihse I and Wadstrom
T: Helicobacter species ribosomal DNA in the pancreas, stomach and
duodenum of pancreatic cancer patients. World J Gastroenterol.
12:3038–3043. 2006.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Lindén SK, Wickström C, Lindell G,
Gilshenan K and Carlstedt I: Four modes of adhesion are used during
Helicobacter pylori binding to human mucins in the oral and
gastric niches. Helicobacter. 13:81–93. 2008.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Umeda M, Kobayashi H, Takeuchi Y, Hayashi
J, Morotome-Hayashi Y, Yano K, Aoki A, Ohkusa T and Ishikawa I:
High prevalence of Helicobacter pylori detected by PCR in
the oral cavities of periodontitis patients. J Periodontol.
74:129–134. 2003.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Wei X, Zhao HQ, Ma C, Zhang AB, Feng H,
Zhang D and Liu C: The association between chronic periodontitis
and oral Helicobacter pylori: A meta-analysis. PLoS One.
14(e0225247)2019.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Hirabayashi M, Inoue M, Sawada N, Saito E,
Abe SK, Hidaka A, Iwasaki M, Yamaji T, Shimazu T and Tsugane S:
Helicobacter pylori infection, atrophic gastritis, and risk
of pancreatic cancer: A population-based cohort study in a large
Japanese population: The JPHC study. Sci Rep.
9(6099)2019.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Stolzenberg-solomon RZ, Blaser MJ, Limburg
PJ, Perez-Perez G, Taylor RP, Virtamo J and Albanes D:
Helicobacter pylori seropositivity as a risk factor for
pancreatic cancer. J Natl Cancer Inst. 93:937–941. 2001.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Trikudanathan G, Philip A, Dasanu CA and
Baker WL: Association between Helicobacter pylori infection
and pancreatic cancer. A cumulative meta-analysis. JOP. 12:26–31.
2011.PubMed/NCBI
|
|
92
|
Risch HA: Pancreatic cancer:
Helicobacter pylori colonization, N-nitrosamine exposures,
and ABO blood group. Mol Carcinog. 51:109–118. 2012.PubMed/NCBI View Article : Google Scholar
|
